Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
- 2003 -
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
Oktober 2003 - 13 products
L
SIP
IP
CI
Ebixa 10 mg
50 Tablet(s)
48.60
69.00
10 %
Coated tablets: Memantini Hydrochloridum 10 mg
Lundbeck (Schweiz) AG
B / SL / SO
FB
G
L
SIP
IP
CI
Ebixa 20 mg
98 Tablet(s)
183.17
214.60
10 %
Coated tablets: Memantini Hydrochloridum 20 mg
Lundbeck (Schweiz) AG
B / SL / SO
FB
G
L
SIP
IP
CI
Ebixa 5 mg, 10 mg
7 Kombipackung(en)
33.18
52.15
10 %
mg: Memantini Hydrochloridum 5 mg
mg: Memantini Hydrochloridum 10 mg
mg: Memantini Hydrochloridum 15 mg
mg: Memantini Hydrochloridum 20 mg
Lundbeck (Schweiz) AG
B / SL / SO
FB
G
IP
CI
Dafalgan 1 g
‐
I
-
T
16 Tablet(s)
2.68
12.15
10 %
Coated tablets: Paracetamolum 1 g
UPSA Switzerland AG
B / SL
FB
G
IP
CI
Dafalgan 1 g
‐
I
-
T
40 Tablet(s)
6.23
16.00
10 %
Coated tablets: Paracetamolum 1 g
UPSA Switzerland AG
B / SL
FB
G
IP
CI
Dafalgan 1 g
‐
I
-
T
100 Tablet(s)
13.24
30.80
10 %
Coated tablets: Paracetamolum 1 g
UPSA Switzerland AG
B / SL
FB
G
IP
CI
A
Oxynorm
30 ml
15.94
33.75
10 %
Solution (oral): Oxycodoni Hydrochloridum 10 mg/ml
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
A+ / SL
FB
G
L
IP
V/S
Fibrogammin 250 I.E.
Set(s)
170.88
216.35
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung: Factor Xiii 250 UI
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Fibrogammin 1'250 I.E.
Set(s)
854.49
917.75
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung: Factor Xiii 1250 UI
CSL Behring AG
B / SL
FB
G
L
IP
V/S
FSME-Immun 0.25 ml Junior
Fertigspritze(n)
26.79
45.55
10 %
Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 1.19µg / 0.25ml
Pfizer AG
B / SL
FB
G
L
IP
V/S
FSME-Immun 0.25 ml Junior
10 Fertigspritze(n)
267.90
307.75
10 %
Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 1.19µg / 0.25ml
Pfizer AG
B / SL
FB
G
IP
CI
CM
Treupel Dolo forte
Ibuprofen 400
10 Tablet(s)
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
MEDA Pharma GmbH
D
FB
G
IP
CI
A
Oxynorm
120 ml
PR
PR
k.A.
Solution (oral): Oxycodoni Hydrochloridum 10 mg/ml
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
A+
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
